DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)
South Korea · Delayed Price · Currency is KRW 5,060.00
-230.00 (-4.35%)
At close: Mar 31, 2026
DongKoo Bio & Pharma Market Cap
DongKoo Bio & Pharma has a market cap or net worth of 136.83 billion as of April 1, 2026. Its market cap has increased by 1.40% in one year.
Market Cap
136.83B
Enterprise Value
230.91B
Revenue
238.39B
Ranking
n/a
PE Ratio
177.77
Stock Price
5,060.00
Market Cap Chart
Since February 19, 2018, DongKoo Bio & Pharma's market cap has decreased from 369.75B to 136.83B, a decrease of -62.99%. That is a compound annual growth rate of -11.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 142.78B | -3.47% |
| Dec 30, 2025 | 147.92B | 12.87% |
| Dec 30, 2024 | 131.05B | -16.18% |
| Dec 28, 2023 | 156.35B | -7.82% |
| Dec 29, 2022 | 169.61B | -27.07% |
| Dec 30, 2021 | 232.56B | -3.34% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vivozon Pharmaceutical | 157.82B |
| Organoidsciences | 156.74B |
| Kyung Dong Pharmaceutical | 147.91B |
| PHARMARESEARCH BIO | 132.95B |
| Pharos iBio | 129.46B |
| KOREA PHARMA | 126.52B |
| HYUNDAI BIOLAND | 123.00B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 111.43B |